According to Future Market Insights research, during the projected period, the global enteric softgel capsules market is expected to grow at a CAGR of 6.7%. The market value is projected to increase from US$ 305.3 million in 2023 to US$ 582.5 million by 2033. The enteric softgel capsules market was valued at US$ 288.8 million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 5.7% in 2023.
Market Outlook:
Key Market Attributes
| Market Size, 2022 | US$ 288.8 Million |
|---|---|
| Market Size, 2023 | US$ 305.3 Million |
| Market Size, 2033 | US$ 582.5 Million |
| Value CAGR (2023 to 2033) | 6.7% |
Soft gelatin capsules are used to contain powders or water-insoluble liquids that have been dissolved in a non-polar solvent for a number of purposes, including disguising tastes or offensive odors, lowering product contamination, and safeguarding the active medication against oxidation. In order to limit gastrointestinal irritation from the medication and to prevent the active ingredients from being degraded by the gastric juice, gastric-resistant capsules are utilized. Only at enteric pH may the medication be released due to the gastric-resistant coating.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global enteric softgel capsules market recorded a historic CAGR of 5.7% in the last 5 years from 2017 to 2022. The market value for the enteric softgel capsules market was around 25.8% of the overall US$ 1.1 billion of the global softgel capsules market.
Semi Annual Market Update
| Particulars | Value CAGR |
|---|---|
| H1 | 6.22% (2022 to 2032) |
| H2 | 6.98% (2022 to 2032) |
| H1 | 5.99% (2023 to 2033) |
| H2 | 7.35% (2023 to 2033) |
A dynamic and quickly developing sector of the pharmaceutical and nutraceutical industries is the enteric softgel capsules industry. The enteric coating on these specialty capsules allows them to pass through the stomach unharmed and dissolve in the intestines, allowing the best possible absorption of the active components.
The market is expected to increase due to factors such as the rising need for cutting-edge medication delivery systems, the rising acceptance of dietary supplements, and the requirement for efficient treatments for gastrointestinal illnesses. In order to satisfy consumer preferences for simple administration and improved bioavailability, enteric softgel capsules provide a flexible and practical choice for delivering delicate medications and nutrients.
The enteric softgel capsules market offers prospective opportunities for pharmaceutical businesses, supplement makers, and customers seeking effective and tailored treatment outcomes due to ongoing improvements in manufacturing technology and research initiatives.
The market for enteric softgel capsules is significantly influenced by the global increase in gastrointestinal illnesses. There is a rising need for efficient drug delivery methods that may target the intestines while avoiding the harsh stomach environment as the prevalence of illnesses including acid reflux, ulcerative colitis, and Crohn's disease continues to rise globally.
By applying specific coatings, enteric softgel capsules provide a remedy by ensuring the safe transit of active components to the intestines and preventing early disintegration in the stomach. This makes it possible to treat gastrointestinal problems effectively and improve the therapeutic effects of drugs.
Thus, the potential of enteric softgel capsules to enhance bioavailability and ensure that pharmaceuticals are delivered where they are most required, aligning with the growing healthcare needs of a population dealing with gastrointestinal health conditions globally, is what drives demand for these products.
Principal Consultant
The enteric softgel capsules market is significantly constrained in its ability to grow due to limited compatibility. The compatibility of formulations with enteric coating materials limits the use of these capsules, despite the fact that they present a promising method for the targeted delivery of medications and the protection of delicate constituents.
On other hand, some active components might not be good candidates for enteric softgel encapsulation, particularly if they are sensitive to certain coatings or unable to tolerate the enteric process. This restriction may hamper the development of novel medications and nutraceuticals that could benefit from enteric delivery as well as the growth of product offers.
Formulators and manufacturers must overcome these obstacles, which could result in extended research and development cycles, increased costs, and less market opportunities. Unlocking the full potential of enteric softgel capsules in various therapeutic applications is dependent on improvements in enteric coating materials and methods that address limited compatibility.
| Countries | Value CAGR |
|---|---|
| United States | 8.7% |
| Germany | 6.3% |
| United Kingdom | 6.9% |
| Japan | 7.1% |
| China | 6.7% |
| India | 6.7% |
The United States dominates the global market with a 28.5% market share in 2022 and is projected to continue experiencing high growth throughout the forecast period.
The United States pharmaceutical and nutraceutical industries are developing, which is boosting the demand for enteric softgel capsules. There is an increasing need for efficient and specialized delivery systems, such as enteric softgel capsules, as these sectors continue to create novel medications and supplements.
These capsules shield delicate chemicals from stomach acids, ensuring ideal intestinal absorption and boosting medicinal effectiveness. This need is also fueled by the trend toward targeted medicines and customized medicine.
Since the United States is a prominent center for pharmaceutical and nutraceutical research, development, and manufacture, the growing use of enteric softgel capsules is consistent with the sectors' desire for cutting-edge and effective drug delivery solutions, greatly boosting market growth.
China dominates the global market with 8.1% of the market share in 2022. The rising demand for nutritional supplements in China, fueled by increasing awareness of malnutrition-related concerns, drives the growth of the enteric softgel capsules market.
These capsules offer effective nutrient delivery, aiding in combatting malnutrition by ensuring optimal absorption in the intestines. As consumers prioritize wellness and seek convenient dosage forms, enteric softgel capsules play a crucial role in addressing nutritional deficiencies, aligning with China's efforts to improve public health and nutrition outcomes.
India holds about 6.9% share of the global market in 2022 and is projected to increase during the forecast period. The increase in the incidence of inflammatory bowel disease (IBD) is driving the market for enteric softgel capsules in India. The need for targeted medicine delivery to the intestines is growing as IBD, which includes diseases like Crohn's disease and ulcerative colitis, grows increasingly common.
With their protective coating, enteric softgel capsules allow for efficient medication release in the lower digestive tract, improving therapeutic results and patient comfort. The use of enteric softgel capsules in the Indian pharmaceutical market is being driven by the expanding demand for specific medication delivery methods that are in line with the increase in IBD cases.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Market Growth Outlook by Key Product
| Product | Value CAGR |
|---|---|
| Gelatin Softgel Capsules | 5.6% |
| Vegetarian Softgel Capsules | 10.0% |
Gelatin softgel capsules within the product segment hold a revenue share of 74.3% in 2022, and the same trend is being followed over the forecasted period. Gelatin softgel capsules' dominance in the enteric softgel capsule industry can be due to its successful record of accomplishment, widespread acceptability, and affordability. Gelatin is frequently used to deliver delicate substances while maintaining good absorption in the intestines due to its compatibility with enteric coatings and its established manufacturing procedures.
Market Growth Outlook by Key Raw Material
| Raw Material | Value CAGR |
|---|---|
| Type-A Gelatin (Pork Skin) | 5.0% |
| Type-B Gelatin (Animal Bones & Skin) | 6.2% |
| Fish Bone Gelatin | 7.3% |
| Cellulose Derivatives | 9.4% |
| Starch Material | 11.4% |
Type-A Gelatin (Pork Skin) held a market share of 42.9% in 2022 due to its wide availability, compatibility with enteric coating procedures, and affordability, Type-A Gelatin (Pork Skin) is a recommended option for formulation because it provides consistent performance in establishing intestinal barriers, guaranteeing adequate drug release, and adhering to regulatory criteria.
Market Growth Outlook by Key Application
| Application | Value CAGR |
|---|---|
| Antacid & Antiflatulent Preparations | 4.6% |
| Anti-inflammatory Drugs | 3.7% |
| Antibiotic & Antibacterial Drugs | 2.8% |
| Cough & Cold Preparations | 6.9% |
| Health Supplements | 7.5% |
| Vitamin & Dietary Supplements | 8.2% |
| Other Therapeutic Applications | 1.6% |
The vitamin and Dietary Supplements segment dominates the application segment holding 33.3% market share in 2022. The enteric softgel capsules market is dominated by the vitamin and dietary supplements segment as a result of rising consumer interest in health and wellness as well as the convenience and improved absorption provided by enteric coatings. These capsules efficiently distribute and safeguard delicate nutrients, meeting the requirement for efficient nutritional dietary supplements.
Market Growth Outlook by Key End User
| End User | Value CAGR |
|---|---|
| Pharmaceutical Companies | 8.3% |
| Nutraceutical Companies | 5.8% |
| Cosmeceutical Companies | 4.4% |
| Food Industry | 6.8% |
Pharmaceutical companies segment dominate the dosage segment holding 33.6% market share in 2022. Due to their extensive research, strong drug development skills, and broad drug pipelines, pharmaceutical companies dominate the end-user segment for enteric softgel capsules. The precise medication distribution provided by enteric softgel capsules improves therapeutic results and is in line with pharmaceutical companies' emphasis on cutting-edge formulations for efficient therapies and patient care.
Strategic partnerships are a priority for leading enteric softgel capsules companies as they work to create new product lines and expand their global consumer base.
Similarly, recent developments related to companies in the enteric softgel capsules market have been tracked by the team at Future Market Insights, which are available in the full report.
Related Market Growth Outlook Scenario
| Particulars | Value CAGR |
|---|---|
| Softgel Capsules Market | 5.9% |
| Hard Gelatin Capsules Market | 6.3% |
| Empty Capsules Market | 7.9% |
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2017 to 2022 |
| Market Analysis | US$ Million for Value |
| Key Regions Covered | North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East and Africa |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa, and North Africa |
| Key Market Segments Covered | Product, Raw Material, Application, End User, and Region |
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives |
| Pricing | Available upon Request |
The global market is currently valued at around USD 288.8 million in 2022.
The global market is set to reach a valuation of around USD 582.5 million by the end of 2033.
Gelatin softgel capsules segment, within the product segment, held 74.3% share of the global market in 2022.
Demand for the global market increased at a 5.7% CAGR from 2017 to 2022.
The global estimate for 2023 is around USD 305.3 Million.
The United States accounts for around 28.5% share of the global market in 2022.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation/Development Trends
4. Value Added Insights
4.1. Adoption Rate for Enteric Softgel Capsules
4.2. Regulatory Landscape
4.3. PESTLE Analysis
4.4. Porter's Analysis
4.5. Pipeline Assessment
4.6. Unmet Needs
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global Healthcare Expenditure Outlook
5.1.2. Global Parent Market Analysis (Global Softgel Capsules Market)
5.1.3. Global Research and Development Funding by Region
5.2. Forecast Factors - Relevance and Impact
5.2.1. Awareness of Enteric Softgel Capsules
5.2.2. Increasing Prevalence of Chronic Disease
5.2.3. Growing Investment in Healthcare Expenditure
5.2.4. Novel Products
5.2.5. Top Companies’ Historical Growth
5.2.6. Product-Based Cost
5.2.7. Strategic Collaboration and Partnership
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
6.1. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
6.2. Historical Market Value (US$ Million) Analysis, 2017 to 2022
6.3. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
6.3.1. Y-o-Y Growth Trend Analysis
6.3.2. Absolute $ Opportunity Analysis
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Million) Analysis by Product, 2017 to 2022
7.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Product, 2023 to 2033
7.3.1. Gelatin Softgel Capsules
7.3.2. Vegetarian Softgel Capsules
7.4. Market Attractiveness Analysis by Product
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Raw Material
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis by Raw Material, 2017 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Raw Material, 2023 to 2033
8.3.1. Type-A Gelatin (Pork Skin)
8.3.2. Type-B Gelatin (Animal Bones and Skin)
8.3.3. Fish Bone Gelatin
8.3.4. Cellulose Derivatives
8.3.5. Starch Material
8.4. Market Attractiveness Analysis by Raw Material
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis by Application, 2017 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2023 to 2033
9.3.1. Antacid and Antiflatulent Preparations
9.3.2. Anti-inflammatory Drugs
9.3.3. Antibiotic and Antibacterial Drugs
9.3.4. Cough and Cold Preparations
9.3.5. Health Supplements
9.3.6. Vitamin and Dietary Supplements
9.3.7. Other Therapeutic Applications
9.4. Market Attractiveness Analysis by Application
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis by End User, 2017 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2023 to 2033
10.3.1. Pharmaceutical Companies
10.3.2. Nutraceutical Companies
10.3.3. Cosmeceutical Companies
10.3.4. Food Industry
10.4. Market Attractiveness Analysis by End User
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis by Region, 2017 to 2022
11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Region, 2023 to 2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa
11.4. Market Attractiveness Analysis by Region
12. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Historical Market Size (US$ Million) Trend Analysis by Market Taxonomy, 2017 to 2022
12.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
12.3.1. By Country
12.3.1.1. United States
12.3.1.2. Canada
12.3.2. By Product
12.3.3. By Raw Material
12.3.4. By Application
12.3.5. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Product
12.4.3. By Raw Material
12.4.4. By Application
12.4.5. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis and Forecast
12.8.1. United States Market
12.8.1.1. Introduction
12.8.1.2. Market Analysis and Forecast by Market Taxonomy
12.8.1.2.1. By Product
12.8.1.2.2. By Raw Material
12.8.1.2.3. By Application
12.8.1.2.4. By End User
12.8.2. Canada Market
12.8.2.1. Introduction
12.8.2.2. Market Analysis and Forecast by Market Taxonomy
12.8.2.2.1. By Product
12.8.2.2.2. By Raw Material
12.8.2.2.3. By Application
12.8.2.2.4. By End User
13. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
13.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product
13.3.3. By Raw Material
13.3.4. By Application
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Product
13.4.3. By Raw Material
13.4.4. By Application
13.4.5. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis and Forecast
13.8.1. Brazil Market Analysis
13.8.1.1. Introduction
13.8.1.2. Market Analysis and Forecast by Market Taxonomy
13.8.1.2.1. By Product
13.8.1.2.2. By Raw Material
13.8.1.2.3. By Application
13.8.1.2.4. By End User
13.8.2. Mexico Market Analysis
13.8.2.1. Introduction
13.8.2.2. Market Analysis and Forecast by Market Taxonomy
13.8.2.2.1. By Product
13.8.2.2.2. By Raw Material
13.8.2.2.3. By Application
13.8.2.2.4. By End User
13.8.3. Argentina Market Analysis
13.8.3.1. Introduction
13.8.3.2. Market Analysis and Forecast by Market Taxonomy
13.8.3.2.1. By Product
13.8.3.2.2. By Raw Material
13.8.3.2.3. By Application
13.8.3.2.4. By End User
14. Europe Market 2017 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
14.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. France
14.3.1.3. Spain
14.3.1.4. Italy
14.3.1.5. BENELUX
14.3.1.6. United Kingdom
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product
14.3.3. By Raw Material
14.3.4. By Application
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Raw Material
14.4.4. By Application
14.4.5. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis and Forecast
14.8.1. Germany Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Raw Material
14.8.1.2.3. By Application
14.8.1.2.4. By End User
14.8.2. France Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Raw Material
14.8.2.2.3. By Application
14.8.2.2.4. By End User
14.8.3. Spain Market Analysis
14.8.3.1. Introduction
14.8.3.2. Market Analysis and Forecast by Market Taxonomy
14.8.3.2.1. By Product
14.8.3.2.2. By Raw Material
14.8.3.2.3. By Application
14.8.3.2.4. By End User
14.8.4. Italy Market Analysis
14.8.4.1. Introduction
14.8.4.2. Market Analysis and Forecast by Market Taxonomy
14.8.4.2.1. By Product
14.8.4.2.2. By Raw Material
14.8.4.2.3. By Application
14.8.4.2.4. By End User
14.8.5. BENELUX Market Analysis
14.8.5.1. Introduction
14.8.5.2. Market Analysis and Forecast by Market Taxonomy
14.8.5.2.1. By Product
14.8.5.2.2. By Raw Material
14.8.5.2.3. By Application
14.8.5.2.4. By End User
14.8.6. United Kingdom Market Analysis
14.8.6.1. Introduction
14.8.6.2. Market Analysis and Forecast by Market Taxonomy
14.8.6.2.1. By Product
14.8.6.2.2. By Raw Material
14.8.6.2.3. By Application
14.8.6.2.4. By End User
14.8.7. Russia Market Analysis
14.8.7.1. Introduction
14.8.7.2. Market Analysis and Forecast by Market Taxonomy
14.8.7.2.1. By Product
14.8.7.2.2. By Raw Material
14.8.7.2.3. By Application
14.8.7.2.4. By End User
15. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
15.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Product
15.3.3. By Raw Material
15.3.4. By Application
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Raw Material
15.4.4. By Application
15.4.5. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis and Forecast
15.8.1. China Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Raw Material
15.8.1.2.3. By Application
15.8.1.2.4. By End User
15.8.2. Japan Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Raw Material
15.8.2.2.3. By Application
15.8.2.2.4. By End User
15.8.3. South Korea Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Raw Material
15.8.3.2.3. By Application
15.8.3.2.4. By End User
16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
16.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
16.3.1. By Country
16.3.1.1. India
16.3.1.2. Indonesia
16.3.1.3. Thailand
16.3.1.4. Malaysia
16.3.1.5. Rest of South Asia
16.3.2. By Product
16.3.3. By Raw Material
16.3.4. By Application
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Raw Material
16.4.4. By Application
16.4.5. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis and Forecast
16.8.1. India Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Raw Material
16.8.1.2.3. By Application
16.8.1.2.4. By End User
16.8.2. Indonesia Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Raw Material
16.8.2.2.3. By Application
16.8.2.2.4. By End User
16.8.3. Thailand Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Raw Material
16.8.3.2.3. By Application
16.8.3.2.4. By End User
16.8.4. Malaysia Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Raw Material
16.8.4.2.3. By Application
16.8.4.2.4. By End User
17. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
17.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product
17.3.3. By Raw Material
17.3.4. By Application
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Raw Material
17.4.4. By Application
17.4.5. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis and Forecast
17.8.1. Australia Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Raw Material
17.8.1.2.3. By Application
17.8.1.2.4. By End User
17.8.2. New Zealand Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Raw Material
17.8.2.2.3. By Application
17.8.2.2.4. By End User
18. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
18.1. Introduction
18.2. Historical Market Size (US$ Million) Analysis by Market Taxonomy, 2017 to 2022
18.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Market Taxonomy, 2023 to 2033
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Türkiye
18.3.1.3. Northern Africa
18.3.1.4. South Africa
18.3.1.5. Rest Of Middle East and Africa
18.3.2. By Product
18.3.3. By Raw Material
18.3.4. By Application
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Raw Material
18.4.4. By Application
18.4.5. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis and Forecast
18.8.1. GCC Countries Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Raw Material
18.8.1.2.3. By Application
18.8.1.2.4. By End User
18.8.2. Türkiye Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Raw Material
18.8.2.2.3. By Application
18.8.2.2.4. By End User
18.8.3. Northern Africa Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Raw Material
18.8.3.2.3. By Application
18.8.3.2.4. By End User
18.8.4. South Africa Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Raw Material
18.8.4.2.3. By Application
18.8.4.2.4. By End User
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis
19.3.1. Regional footprint of Players
19.3.2. Product footprint by Players
19.3.3. Channel footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. GELITA AG
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Key Financials
20.3.1.4. Sales Footprint
20.3.1.5. SWOT Analysis
20.3.1.6. Key Developments
20.3.1.7. Strategy Overview
20.3.1.7.1. Channel Strategy
20.3.1.7.2. Marketing Strategy
20.3.1.7.3. Product Strategy
20.3.2. Catalent, Inc,
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Key Financials
20.3.2.4. Sales Footprint
20.3.2.5. SWOT Analysis
20.3.2.6. Key Developments
20.3.2.7. Strategy Overview
20.3.2.7.1. Channel Strategy
20.3.2.7.2. Marketing Strategy
20.3.2.7.3. Product Strategy
20.3.3. Renown Pharmaceuticals Pvt. Ltd.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Key Financials
20.3.3.4. Sales Footprint
20.3.3.5. SWOT Analysis
20.3.3.6. Key Developments
20.3.3.7. Strategy Overview
20.3.3.7.1. Channel Strategy
20.3.3.7.2. Marketing Strategy
20.3.3.7.3. Product Strategy
20.3.4. InovoBiologic Inc
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Key Financials
20.3.4.4. Sales Footprint
20.3.4.5. SWOT Analysis
20.3.4.6. Key Developments
20.3.4.7. Strategy Overview
20.3.4.7.1. Channel Strategy
20.3.4.7.2. Marketing Strategy
20.3.4.7.3. Product Strategy
20.3.5. Viva Pharmaceutical
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Key Financials
20.3.5.4. Sales Footprint
20.3.5.5. SWOT Analysis
20.3.5.6. Key Developments
20.3.5.7. Strategy Overview
20.3.5.7.1. Channel Strategy
20.3.5.7.2. Marketing Strategy
20.3.5.7.3. Product Strategy
20.3.6. Aenova Group
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Key Financials
20.3.6.4. Sales Footprint
20.3.6.5. SWOT Analysis
20.3.6.6. Key Developments
20.3.6.7. Strategy Overview
20.3.6.7.1. Channel Strategy
20.3.6.7.2. Marketing Strategy
20.3.6.7.3. Product Strategy
20.3.7. Basf Se
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Key Financials
20.3.7.4. Sales Footprint
20.3.7.5. SWOT Analysis
20.3.7.6. Key Developments
20.3.7.7. Strategy Overview
20.3.7.7.1. Channel Strategy
20.3.7.7.2. Marketing Strategy
20.3.7.7.3. Product Strategy
20.3.8. Lonza Group Ltd
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Key Financials
20.3.8.4. Sales Footprint
20.3.8.5. SWOT Analysis
20.3.8.6. Key Developments
20.3.8.7. Strategy Overview
20.3.8.7.1. Channel Strategy
20.3.8.7.2. Marketing Strategy
20.3.8.7.3. Product Strategy
20.3.9. Procaps Laboratory
20.3.9.1. Overview
20.3.9.2. Product Portfolio
20.3.9.3. Key Financials
20.3.9.4. Sales Footprint
20.3.9.5. SWOT Analysis
20.3.9.6. Key Developments
20.3.9.7. Strategy Overview
20.3.9.7.1. Channel Strategy
20.3.9.7.2. Marketing Strategy
20.3.9.7.3. Product Strategy
20.3.10. Sirio Pharma Co Ltd.
20.3.10.1. Overview
20.3.10.2. Product Portfolio
20.3.10.3. Key Financials
20.3.10.4. Sales Footprint
20.3.10.5. SWOT Analysis
20.3.10.6. Key Developments
20.3.10.7. Strategy Overview
20.3.10.7.1. Channel Strategy
20.3.10.7.2. Marketing Strategy
20.3.10.7.3. Product Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Explore Healthcare Insights
View Reports
Enteric Softgel Capsules Market
